| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/20/1992 | CA2051754A1 Stabilized pvc products and their production |
| 03/19/1992 | WO1992004408A1 Shaped articles as obtained from a thermoplastic starch melt |
| 03/19/1992 | WO1992004392A1 Polymers containing diester units |
| 03/19/1992 | WO1992004052A1 Modified antibodies with controlled clearance time |
| 03/19/1992 | WO1992004009A1 Liposomes |
| 03/19/1992 | WO1991018981A3 Neurotropic growth factors comprising a homeobox peptide |
| 03/19/1992 | DE4029585A1 Stabilisation of sterilised pharmaceutical solns. - by adding phosphinic acid or its salt or ester prior to sterilisation to protect components sensitive to oxidn. |
| 03/18/1992 | WO1992004915A1 Improved vaccine compositions |
| 03/18/1992 | EP0475851A1 Antioxydant system based on basic aminoacid and a tocopherol |
| 03/18/1992 | EP0475664A1 Lubricant composition and use thereof |
| 03/18/1992 | EP0475482A1 Stabilized solid chemical compositions |
| 03/18/1992 | EP0475230A1 Methods of conjugating actinomycin D |
| 03/18/1992 | EP0475160A1 Preparation for drug application in minute droplet form |
| 03/18/1992 | EP0475130A2 Siloxane derivatives, producing method thereof and agents including siloxane derivative |
| 03/18/1992 | EP0474714A1 A fructose-based granulated product and a process for the production thereof. |
| 03/18/1992 | EP0474647A1 Method and device for the release of drugs to the skin. |
| 03/18/1992 | EP0450080A4 Composition for the treatment of progressive myopia |
| 03/18/1992 | EP0318567B1 ''meso-lactide'' and process for manufacturing it |
| 03/18/1992 | EP0293465B1 Phospholipid composition |
| 03/18/1992 | EP0243369B1 9-halogen prostaglandine clathrates and utilization thereof as drugs |
| 03/18/1992 | CN1059468A Ointments containing tricyclic compound |
| 03/18/1992 | CA2090673A1 Vaccine compositions |
| 03/18/1992 | CA2048089A1 Chemical conjugation of morpholino anthracyclines to antibodies |
| 03/17/1992 | US5097020 Immunogenic conjugates |
| 03/17/1992 | US5096926 Injectable formulations containing the sodium salt of naproxen |
| 03/17/1992 | US5096896 Pyrimethamine and injectable diluent which is the reaction product of acrolein tetramer and an alcohol or acid |
| 03/17/1992 | US5096891 Adenosine 3',5'-cyclic phosphate; dextrin, dextran and/or cyclodextrin; polymeric aluminum hydroxide gel, magnesium silicate and/or hydrotalcite; skin ulcers |
| 03/17/1992 | US5096885 Containing glycine, mannitol and a buffer; stabilization for freeze drying |
| 03/17/1992 | US5096714 Prolonged release drug tablet formulations |
| 03/17/1992 | US5096694 Compounds which are useful, in particular, for radiotherapy or imaging of cancer |
| 03/17/1992 | CA1297627C Biologically degradable polymers for depot preparations havingcontrolled release of the active compound |
| 03/17/1992 | CA1297409C Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
| 03/14/1992 | CA2025282A1 Process for preparing collagen-based composition product produced thereby, and method of applying same |
| 03/12/1992 | DE4028622A1 Prepn. of collagen sponges for cosmetic and pharmaceutical use - by alkali treatment to denature surface, acid treatment, washing comminution, freezing and freeze drying |
| 03/12/1992 | CA2048094A1 Methods of conjugating actinomycin d |
| 03/11/1992 | EP0474453A2 Pharmaceutical composition comprising an active peptide or protein and a heat-labile enterotoxin B and its mucous use |
| 03/11/1992 | EP0474126A1 Ointments containing tricyclic compound |
| 03/11/1992 | EP0474098A1 Controlled drug release composition |
| 03/11/1992 | EP0474040A1 Efferescent powder component and process for its production |
| 03/11/1992 | EP0473811A1 Ointment containing deprodone proprionate |
| 03/11/1992 | EP0473810A1 Water and deprodone proprionate -containing external preparations |
| 03/11/1992 | EP0473721A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 03/11/1992 | EP0473707A1 Injectable clarithromycin composition |
| 03/11/1992 | EP0473651A1 Monoclonal antibodies which recognise malignant cells from bladder carcinomas |
| 03/11/1992 | EP0169214B1 Anti-oestrogen drug for percutaneous administration |
| 03/11/1992 | CN1059346A Shaped apticles as obtained from thermoplastic starch melt |
| 03/11/1992 | CN1059278A 抗体共轭物 Antibody conjugate |
| 03/11/1992 | CN1059277A Local drug delivery compositions for dental use |
| 03/11/1992 | CN1059276A Pharmaceutical composition of florfenicol |
| 03/11/1992 | CA2050358A1 Lubricant composition and use thereof |
| 03/10/1992 | US5095097 Diagnostics |
| 03/10/1992 | US5095054 Polymer compositions containing destructurized starch |
| 03/10/1992 | US5094851 Corticosteroids |
| 03/10/1992 | US5094849 Antitumor |
| 03/10/1992 | US5094848 Cleavable diphosphate and amidated diphosphate linkers |
| 03/10/1992 | CA1297029C Topical metronidazole formulations and therapeutical uses thereof |
| 03/10/1992 | CA1297026C Brompheniramine, pseudoephedrine therapy |
| 03/10/1992 | CA1297025C Controlled release hydromorphone composition |
| 03/10/1992 | CA1297024C Drug compositions stabilized against oxidation |
| 03/10/1992 | CA1297023C Stabilized drug composition containing ascorbic acid |
| 03/10/1992 | CA1297019C Method for the preparation of sustained release bolus formulation |
| 03/10/1992 | CA1297017C Controlled release pharmaceutical composition |
| 03/10/1992 | CA1297016C Sustained release pharmaceutical preparations |
| 03/10/1992 | CA1297014C Multilamellar liposomes having improved trapping efficiencies |
| 03/10/1992 | CA1297013C Ointment base |
| 03/10/1992 | CA1297012C Pharmaceutical compositions for inhalation |
| 03/10/1992 | CA1297007C Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same |
| 03/05/1992 | WO1992004031A1 Preservation of blood, tissues and biological fluids |
| 03/05/1992 | WO1992003733A1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 03/05/1992 | WO1992003569A1 Protein polyligands joined to a stable protein core |
| 03/05/1992 | WO1992003566A1 Therapeutic ribozyme compositions |
| 03/05/1992 | WO1992003537A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | WO1992003163A1 Vaccine and immunoserum against drugs of abuse |
| 03/05/1992 | WO1992003151A1 Uses of recombinant colony stimulating factor-1 |
| 03/05/1992 | WO1992003141A1 Topical compositions and methods for treatment of male impotence |
| 03/05/1992 | WO1992003126A1 Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure |
| 03/05/1992 | WO1992003124A1 Controlled release formulations and method |
| 03/05/1992 | WO1992003122A1 Preparation for application of active substances in the form of minimum-sized droplets |
| 03/05/1992 | WO1992003121A1 Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories |
| 03/05/1992 | CA2090105A1 Protein polyligands joined to a stable protein core |
| 03/05/1992 | CA2089497A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | CA2072871A1 Preservation of blood, tissues and biological fluids |
| 03/04/1992 | EP0473431A1 Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
| 03/04/1992 | EP0473395A1 Use of Rhamsan gum for the manufacture of a teat treating composition |
| 03/04/1992 | EP0473268A2 Continuous release pharmaceutical compositions comprising a polypeptide covalently conjugated to a water soluble polymer |
| 03/04/1992 | EP0473223A1 Bioerodible implants |
| 03/04/1992 | EP0473159A1 Stable aqueous preparation |
| 03/04/1992 | EP0473084A2 Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides |
| 03/04/1992 | EP0472969A1 External preparation comprising calcium silicate |
| 03/04/1992 | EP0472662A1 Antifreeze polypeptides |
| 03/04/1992 | EP0472639A1 Accumulation of drugs into liposomes by a proton gradient |
| 03/04/1992 | EP0472575A1 Improvements in or relating to pharmaceutical preparations |
| 03/04/1992 | CA2050425A1 Pharmaceutical composition and its mucous use |
| 03/03/1992 | US5093475 Hindered linking agents derived from 2-iminothiolanes and methods |
| 03/03/1992 | US5093372 Used in treatment of dementia, improved solubility, absorption cellulose ethers |
| 03/03/1992 | US5093348 Pharmaceutical composition for topical ophthalmic use having improved local tolerability |
| 03/03/1992 | US5093334 Dermal treatment of worm diseases in cats with praziquantel |
| 03/03/1992 | US5093133 Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
| 03/03/1992 | US5093132 Stabilized pharmaceutical composition and its production |
| 03/03/1992 | US5093127 Cyclodextrin Carrier, Antiallergens |